Purchases and Sales Made in Q3 2022 in Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA) during Q3 2022. The information is specifically focused on institutions that hold shares of IOVANCE BIOTHERAPEUTICS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-402K- 27.73% |
$3.83M - $5.27M
|
1.05M
$9M
|
|
Nov 14, 2022
Q3 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-498K- 16.54% |
$4.74M - $6.53M
|
2.51M
$21.6M
|
|
Oct 17, 2022
Q3 2022
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-618K- 21.07% |
$5.89M - $8.11M
|
2.32M
$19.9M
|
|
Nov 14, 2022
Q3 2022
|
Long Focus Capital Management, LLC
San Juan, PR |
SELL
|
- |
-689K- 42.4% |
$6.57M - $9.03M
|
936K
$8.04M
|
|
Nov 14, 2022
Q3 2022
|
Graham Capital Management, L.P.
Rowayton, CT |
SELL
|
- |
-713K- 73.63% |
$6.8M - $9.35M
|
255K
$2.19M
|
|
Nov 14, 2022
Q3 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-791K- 28.27% |
$7.54M - $10.4M
|
2.01M
$17.2M
|
|
Nov 10, 2022
Q3 2022
|
Bank Of Nova Scotia
|
SELL
|
- |
-1.01M- 98.31% |
$9.63M - $13.2M
|
17.4K
$149K
|
|
Nov 14, 2022
Q3 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-1.54M- 94.07% |
$14.7M - $20.2M
|
97.2K
$835K
|
|
Nov 14, 2022
Q3 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-1.58M- 13.34% |
$15M - $20.7M
|
10.2M
$88M
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.84M- 15.62% |
$17.5M - $24.1M
|
9.93M
$85.3M
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-2.09M- 82.88% |
$19.9M - $27.4M
|
432K
$3.71M
|